Clinical Trials Directory

Trials / Completed

CompletedNCT04083521

Effect of Bacillus Subtilis DE111® on Daily Bowel Movements

The Effect of Bacillus Subtilis DE111® on the Daily Bowel Movement Profile for People With Occasional Gastrointestinal Irregularity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Deerland Enzymes · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the efficacy of Bacillus subtilis DE111® probiotic for regulation of bowel movements.

Detailed description

The purpose of this study is to determine the efficacy of the probiotic B. subtilis DE111® for regulation of bowel movements. A single capsule containing 1 x 10\^9 CFU B. subtilis is to be consumed once a day per participant. 50 adults (18-65 years of age at the time of participation) suffering from occasional constipation and/or diarrhea will be enrolled. Participants will be double-blindly and randomly assigned to either the probiotic (Bacillus subtilis) or the placebo (maltodextrin) group. Efficacy will be assessed with participant-reported bowel movement (BM) records. As a secondary outcome, the study will provide further insight into the tolerance of the supplement. Tolerance will be assessed using a digestive health questionnaire and blood samples to analyze pertinent metabolic biomarkers. Participants will be asked to complete a daily dietary intake record as well. Prior to capsule consumption, participants will complete a two-week pre-testing phase in order to provide a more inclusive diagnostic baseline. This phase will consist of daily BM and dietary intake record keeping.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBacillus subtilis DE111®Subjects were administered a dose of Bacillus subtilis at levels of 1x10\^9 CFU once a day for 90-days.

Timeline

Start date
2016-09-01
Primary completion
2017-08-31
Completion
2017-08-31
First posted
2019-09-10
Last updated
2019-09-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04083521. Inclusion in this directory is not an endorsement.